-
Invest in the future of cancer diagnostics and treatmentNew cancer diagnostics and treatments mean the disease is no longer the death sentence it once was. Here's how you can back these developments
-
Three compelling British stocks the market has overlookedOpinion Three under-appreciated British stocks to buy now, as picked by Dominic Younger, fund manager at Columbia Threadneedle Investments
Opinion -
The top stocks and funds to buy according to DIY investorsInvestors sought out cash funds and dividend-payers in March. Which were the top stocks, funds and investment trusts bought during the month?
-
Legal & General: a veteran FTSE stock with life in it yetLegal & General has changed its focus to a cash-generative, asset-light business. Investors should take note, says Rupert Hargreaves
-
Three profitable Indian stocks for long-term growthOpinion Three Indian stocks to buy for long-term growth, as picked by Ayush Abhijeet of the Ashoka India Equity Investment Trust
Opinion -
Three overlooked UK stocks with turnaround potentialOpinion Three UK stocks to buy with turnaround potential, as picked by Alex Wright, portfolio manager at Fidelity Special Values
Opinion -
Seraphim: The space-focused fund that's ready for lift-offSeraphim Space Investment Trust has graduated from a speculative punt to a more mature growth-stage holding, says Rupert Hargreaves
-
Venture Global: a promising way to play the energy crisisLNG-producer Venture Global is set for a windfall from higher natural gas prices and looks like a promising play on the brewing energy crisis
-
How to play the SSE share priceEnergy provider SSE is going for growth and looks reasonably valued. Should you invest?
